Denali Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,600
Closed -$123K 476
2024
Q1
$123K Hold
13,600
0.04% 264
2023
Q4
$148K Sell
13,600
-13,000
-49% -$141K 0.05% 250
2023
Q3
$214K Sell
26,600
-26,000
-49% -$209K 0.08% 219
2023
Q2
$571K Buy
52,600
+43,000
+448% +$467K 0.2% 129
2023
Q1
$66.2K Buy
+9,600
New +$66.2K 0.03% 200